Amikacin is available as both a generic medication and under the brand name Amikin [1][2].
What is Amikacin used for?
Amikacin is an antibiotic used to treat serious bacterial infections, particularly those caused by Gram-negative bacteria that are resistant to other aminoglycoside antibiotics [3][4]. It is often prescribed for hospital-acquired infections, such as pneumonia, urinary tract infections, and bloodstream infections [4][5].
How does Amikacin work?
Amikacin functions by interfering with bacterial protein synthesis. It binds to the 30S ribosomal subunit of susceptible bacteria, leading to misreading of mRNA and inhibition of protein production, ultimately killing the bacteria [3][4].
Who manufactures Amikacin?
The brand-name Amikin was originally developed by Bristol-Myers Squibb [2]. Generic versions of amikacin are manufactured by various pharmaceutical companies.
When does Amikacin patent expire?
Information regarding the patent expiration for Amikacin, particularly for the brand-name Amikin, is complex due to its history as an older drug. DrugPatentWatch.com is a resource that tracks drug patent and exclusivity information [1]. However, as amikacin has been available generically for a considerable time, its primary patents have long since expired, allowing for generic competition.
What are the side effects of Amikacin?
Common side effects of amikacin include kidney problems (nephrotoxicity), hearing loss (ototoxicity), and nerve damage (neurotoxicity) [3][4]. These risks are often dose-dependent and can be increased with prolonged use or in individuals with pre-existing kidney or hearing issues [3][4]. Regular monitoring of kidney function and hearing may be necessary during treatment [3].
How is Amikacin administered?
Amikacin is typically administered intravenously (IV) or intramuscularly (IM) [4][5]. It is not usually taken orally as it is poorly absorbed from the gastrointestinal tract [4]. Dosing is based on the patient's weight and kidney function [4].
Can Amikacin be used in children?
Amikacin can be used in pediatric patients for serious bacterial infections, with dosages adjusted based on age and weight [4][5].
What are the alternatives to Amikacin?
Depending on the specific type of bacterial infection and the susceptibility of the pathogen, alternative antibiotics may include other aminoglycosides (like gentamicin or tobramycin), cephalosporins, fluoroquinolones, or carbapenems [4]. Treatment decisions are made by healthcare professionals based on diagnostic tests and patient factors [4].
What is the difference between Amikacin and other aminoglycosides?
Amikacin is considered a "broad-spectrum" aminoglycoside, meaning it is effective against a wider range of bacteria, including some that are resistant to other drugs in its class, such as gentamicin and tobramycin [3][4]. This broader spectrum and its relative resistance to some bacterial enzymes make it a valuable option for treating severe, multi-drug resistant infections [3][4].
How is Amikacin regulated?
Amikacin is an FDA-approved medication for use in the United States [1][5]. Its use is subject to prescription and is regulated by health authorities to ensure safety and efficacy.
---
Sources
[1] DrugPatentWatch.com
[2] RxList. Amikin.
[3] National Library of Medicine. Amikacin.
[4] MedlinePlus. Amikacin Injection.
[5] DailyMed. Amikacin Sulfate Injection.